Clear Street Markets LLC Eli Lilly & CO Call Options Transaction History

Clear Street Markets LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 Apr 14, 2021	SELL	$164.32 - $212.72 $3,286 - $4,254	-20 Closed	0 $0
Q4 2020 Feb 25, 2021	SELL	$130.46 - $172.63 $12,393 - $16,399	-95 Reduced 82.61%	20 $3,000
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $15,688 - $18,880	115 New	115 $1.89 Million
Q2 2019 Jul 16, 2019	SELL	$110.79 - $129.32 $167,736 - $195,790	-1,514 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $168,523 - $198,364	1,514 New	1,514 $19.6 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.